Chongqing Liyang Pharmaceutical Development Co., Ltd.
Distinctive Advantages
Innovative Development
The company places particular emphasis on applying for invention patents that can facilitate industrial transformation. To date, its R&D projects have resulted in the authorization of six invention patents, including those related to reduced-form glutathione lozenges, coenzyme Q10 orally disintegrating tablets and their preparation methods, a compound formulation containing telmisartan and amlodipine, as well as a stable candesartan cilexetil-amlodipine drug combination and its corresponding preparation method.
System Assurance
The company has established a quality management system tailored to the realities of pharmaceutical formulation research, based on its unique characteristics and designed to control the quality throughout the drug development process. Drawing upon relevant GLP and GMP guidelines, the company follows the "Plan-Do-Check-Act (PDCA)" operational cycle—comprising planning and design, implementation through operations and experiments, rigorous inspection and verification, and continuous improvement—to systematically enhance and refine its quality management practices. As a result, the company has preliminarily developed a comprehensive set of management responsibilities along with standardized procedures (SMP and SOP documents), ensuring that personnel, equipment, materials, methods, and environmental conditions are managed in accordance with best practices throughout the pharmaceutical formulation research process. This approach guarantees the high quality and reliability of all drug development projects.
Standardized and Efficient
The company boasts a high-quality, highly efficient R&D team comprising experienced pharmaceutical professors, senior engineers, and engineers—many of whom hold master’s degrees or bachelor’s/associate degrees. The team also benefits from the ongoing technical guidance and support of several seasoned experts specializing in drug research and regulatory review. All pharmaceutical research activities are conducted strictly in accordance with relevant national policies, regulations, and technical standards governing drug development. To ensure that employees remain up-to-date and adept at interpreting industry regulations and technical guidelines, the company provides comprehensive internal and external training programs for its core research personnel, while also encouraging self-learning initiatives. This approach enables staff to align their work effectively with project planning, conduct experiments in a rigorous and standardized manner, and ultimately deliver new drug development projects that are both practical and efficient.
National Service Hotline
